Life-saving medicines agar unaffordable ho jayein, to right to health practically meaningless ho jata hai. Isi liye kai deshon me price control mechanisms exist karte hain for essential drugs – specially antibiotics, cancer meds, insulin, cardiac medicines, etc.
Price control ka matlab hota hai government ek maximum retail price (MRP) cap set karti hai, ya profit margins pe limit lagati hai. Pharma companies us ceiling se upar charge nahi kar sakti. Lists periodically update hoti rehti hain, based on disease burden and public health priorities.
Critics bolte hain ki excessive control innovation aur R&D discourage karta hai, industry ko loss me dhakel deta hai, aur availability issues create kar sakta hai. Supporters kehte hain ki medicines koi luxury item nahi; public funding, tax benefits, and volume sales ke sath industry reasonable profit enjoy kar sakta hai without extreme pricing.
Ground level pe problem kabhi-kabhi branded vs generic confusion, unethical prescribing, or stocking issues hoti hain. Patients ke liye best practice: generic options ke bare me doctor se openly poochna, price display check karna, aur overcharging kis bhi suspicion pe bill preserve karke complaint consider karna.
Policy level pe yeh ek continuous tug-of-war hai: patient, pharma, and State ke beech sustainable middle path dhoondna.